Half-year report · Q2

Period2024-01-01 → 2024-06-30
Filed2024-08-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥264m2024-01-01 → 2024-06-30StandaloneNet sales
Revenue¥682m2023-01-01 → 2023-12-31StandaloneNet sales (5-year summary)
Revenue¥359m2023-01-01 → 2023-06-30StandaloneNet sales
Operating income−¥581m2024-01-01 → 2024-06-30StandaloneOperating income
Operating income−¥659m2023-01-01 → 2023-06-30StandaloneOperating income
Ordinary income−¥563m2024-01-01 → 2024-06-30StandaloneOrdinary income
Ordinary income−¥1.2bn2023-01-01 → 2023-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥662m2023-01-01 → 2023-06-30StandaloneOrdinary income
Profit before tax−¥562m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Profit before tax−¥661m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Net income−¥564m2024-01-01 → 2024-06-30StandaloneProfit loss
Net income−¥1.2bn2023-01-01 → 2023-12-31StandaloneNet income loss (5-year summary)
Net income−¥664m2023-01-01 → 2023-06-30StandaloneProfit loss
Total assets¥1.6bnat 2024-06-30StandaloneAssets
Total assets¥1.8bnat 2023-12-31StandaloneAssets
Total assets¥1.7bnat 2023-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥487mat 2024-06-30StandaloneLiabilities
Total liabilities¥594mat 2023-12-31StandaloneLiabilities
Net assets / equity¥1.1bnat 2024-06-30StandaloneNet assets
Net assets / equity¥1.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.1bnat 2023-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2024-06-30StandaloneCash and deposits
Cash and deposits¥1.3bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.2bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.7bnat 2022-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥677m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥595m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥173,0002023-01-01 → 2023-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥82,0002023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥455m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥667m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥113m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-10.212024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.622023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.72023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio68.0%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio65.1%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio67.2%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued56,387,000at 2024-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued52,640,200at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued48,503,800at 2023-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥269m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2024-01-01 → 2024-06-30−¥447m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2024-01-01 → 2024-06-30¥135m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30−¥312m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥266m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2023-01-01 → 2023-06-30−¥602m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2023-01-01 → 2023-06-30¥359m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2023-01-01 → 2023-06-30¥359m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2023-01-01 → 2023-06-30¥209m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥359m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥359m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30−¥393m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Non operating incomeCurrentYTDDuration_NonConsolidatedMember21077000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember910000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember1282000JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember940000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember2004000JPY
Share based payment expenses noePrior1YTDDuration_NonConsolidatedMember654000JPY
Share based payment expenses noeCurrentYTDDuration_NonConsolidatedMember-JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember808000JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember-JPY
Other noePrior1YTDDuration_NonConsolidatedMember0JPY
Other noeCurrentYTDDuration_NonConsolidatedMember0JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember3314000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember3286000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-662139000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-563345000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration_NonConsolidatedMember73000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration_NonConsolidatedMember-JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration_NonConsolidatedMember930000JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration_NonConsolidatedMember1302000JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember1003000JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember1302000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration_NonConsolidatedMember14000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration_NonConsolidatedMember-JPY
Extraordinary lossPrior1YTDDuration_NonConsolidatedMember14000JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember-JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-661150000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-562043000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember2505000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember1915000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember2505000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember1915000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-663655000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-563958000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-661150000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-562043000JPY
Depreciation and amortization ope cfPrior1YTDDuration_NonConsolidatedMember611000JPY
Depreciation and amortization ope cfCurrentYTDDuration_NonConsolidatedMember586000JPY
Subsidy income ope cfPrior1YTDDuration_NonConsolidatedMember-JPY
Subsidy income ope cfCurrentYTDDuration_NonConsolidatedMember-19738000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration_NonConsolidatedMember18308000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration_NonConsolidatedMember32500000JPY
Decrease increase in inventories ope cfPrior1YTDDuration_NonConsolidatedMember11739000JPY
Decrease increase in inventories ope cfCurrentYTDDuration_NonConsolidatedMember11664000JPY
Decrease increase in prepaid expenses ope cfPrior1YTDDuration_NonConsolidatedMember-658000JPY
Decrease increase in prepaid expenses ope cfCurrentYTDDuration_NonConsolidatedMember-40692000JPY
Decrease increase in advance payments ope cfPrior1YTDDuration_NonConsolidatedMember3874000JPY
Decrease increase in advance payments ope cfCurrentYTDDuration_NonConsolidatedMember-20111000JPY
Decrease increase in consumption taxes refund receivable ope cfPrior1YTDDuration_NonConsolidatedMember23394000JPY
Decrease increase in consumption taxes refund receivable ope cfCurrentYTDDuration_NonConsolidatedMember7749000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration_NonConsolidatedMember4197000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-06-30pass